XML 52 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2021
Leases [Abstract]  
Lease costs and supplemental cash flow information
The following table is a summary of the components of net lease cost for the years ended December 31, 2021, 2020 and 2019:
In millions202120202019
Operating lease cost$2,633 $2,670 $2,720 
Finance lease cost:
Amortization of right-of-use assets62 56 38 
Interest on lease liabilities62 58 44 
Total finance lease costs124 114 82 
Short-term lease costs25 22 24 
Variable lease costs604 599 581 
Less: sublease income59 55 50 
Net lease cost$3,327 $3,350 $3,357 

Supplemental cash flow information related to leases for the years ended December 31, 2021, 2020 and 2019 is as follows:
In millions202120202019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows paid for operating leases$2,714 $2,724 $2,701 
Operating cash flows paid for interest portion of finance leases62 58 44 
Financing cash flows paid for principal portion of finance leases50 34 26 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases1,254 1,679 1,824 
Finance leases278 313 283 
Supplemental balance sheet information
Supplemental balance sheet information related to leases as of December 31, 2021 and 2020 is as follows:
In millions, except remaining lease term and discount rate20212020
Operating leases:
Operating lease right-of-use assets$19,122$20,729
Current portion of operating lease liabilities$1,646$1,638
Long-term operating lease liabilities18,17718,757
Total operating lease liabilities$19,823$20,395
Finance leases:
Property and equipment, gross$1,375$1,107
Accumulated depreciation(188)(106)
Property and equipment, net$1,187$1,001
Current portion of long-term debt$50$33
Long-term debt1,2501,050
Total finance lease liabilities$1,300$1,083
Weighted average remaining lease term (in years)
Operating leases12.813.3
Finance leases20.020.3
Weighted average discount rate
Operating leases4.4 %4.5 %
Finance leases5.0 %5.6 %
Maturities of operating lease liabilities
The following table summarizes the maturity of lease liabilities under finance and operating leases as of December 31, 2021:
In millionsFinance
Leases
Operating
Leases
(1)
Total
2022$122 $2,685 $2,807 
2023121 2,613 2,734 
2024111 2,398 2,509 
2025110 2,217 2,327 
2026109 2,054 2,163 
Thereafter1,495 14,103 15,598 
Total lease payments (2)
2,068 26,070 28,138 
Less: imputed interest(768)(6,247)(7,015)
Total lease liabilities$1,300 $19,823 $21,123 
_____________________________________________
(1)Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.
(2)The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.
Maturities of financing lease liabilities
The following table summarizes the maturity of lease liabilities under finance and operating leases as of December 31, 2021:
In millionsFinance
Leases
Operating
Leases
(1)
Total
2022$122 $2,685 $2,807 
2023121 2,613 2,734 
2024111 2,398 2,509 
2025110 2,217 2,327 
2026109 2,054 2,163 
Thereafter1,495 14,103 15,598 
Total lease payments (2)
2,068 26,070 28,138 
Less: imputed interest(768)(6,247)(7,015)
Total lease liabilities$1,300 $19,823 $21,123 
_____________________________________________
(1)Future operating lease payments have not been reduced by minimum sublease rentals of $311 million due in the future under noncancelable subleases.
(2)The Company leases pharmacy and clinic space from Target Corporation. Amounts related to such finance and operating leases are reflected above. Pharmacy lease amounts due in excess of the remaining estimated economic life of the buildings of approximately $2.4 billion are not reflected in this table since the estimated economic life of the buildings is shorter than the contractual term of the pharmacy lease arrangement.